{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:55:15Z","timestamp":1776329715782,"version":"3.50.1"},"reference-count":15,"publisher":"Baskent University","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.6002\/ect.2021.0232","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T04:04:49Z","timestamp":1632283489000},"page":"977-980","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 and Sirolimus Treatment in a Kidney Transplant Recipient"],"prefix":"10.6002","volume":"19","author":[{"given":"Ri","family":"Ra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Sug","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hwan","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Seok","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Stasi C, Fallani S, Voller F, Silvestri C. Treatment for COVID-19: an overview. Eur J Pharmacol. 2020;889:173644. doi:10.1016\/j.ejphar.2020.173644","DOI":"10.1016\/j.ejphar.2020.173644"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Zhu L, Gong N, Liu B, et al. Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China. Eur Urol. 2020;77(6):748-754. doi:10.1016\/j.eururo.2020.03.039","DOI":"10.1016\/j.eururo.2020.03.039"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Dashti-Khavidaki S, Mohammadi K, Khalili H, Abdollahi A. Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19. Expert Opin Pharmacother. 2020;21(15):1813-1819. doi:10.1080\/14656566.2020.1790526","DOI":"10.1080\/14656566.2020.1790526"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Moris D, Kesseli SJ, Barbas AS. Kidney transplant recipients infected by COVID-19: review of the initial published experience. Transpl Infect Dis. 2020;22(6):e13426. doi:10.1111\/tid.13426","DOI":"10.1111\/tid.13426"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-1355. doi:10.1001\/jamainternmed.2020.3539","DOI":"10.1001\/jamainternmed.2020.3539"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Lubetzky M, Aull MJ, Craig-Schapiro R, et al. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center. Nephrol Dial Transplant. 2020;35(7):1250-1261. doi:10.1093\/ndt\/gfaa154","DOI":"10.1093\/ndt\/gfaa154"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Romanelli A, Mascolo S. Immunosuppression drug-related and clinical manifestation of coronavirus disease 2019: a therapeutical hypothesis. Am J Transplant. 2020;20(7):1947-1948. doi:10.1111\/ajt.15905","DOI":"10.1111\/ajt.15905"},{"key":"ref8","unstructured":"9. Sirolimus treatment in hospitalized patients with COVID-19 pneumonia (SCOPE). ClinicalTrials.gov identifier NCT04341675. Updated May 20, 2020. Accessed February 2, 2021. https:\/\/ClinicalTrials.gov\/show\/NCT04341675"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Omarjee L, Janin A, Perrot F, Laviolle B, Meilhac O, Mahe G. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19. Clin Immunol. 2020;216:108464. doi:10.1016\/j.clim.2020.108464","DOI":"10.1016\/j.clim.2020.108464"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Appelberg S, Gupta S, Svensson Akusjarvi S, et al. Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect. 2020;9(1):1748-1760. doi:10.1080\/22221751.2020.1799723","DOI":"10.1080\/22221751.2020.1799723"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 2020;6(1):14. doi:10.1038\/s41421-020-0153-3","DOI":"10.1038\/s41421-020-0153-3"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Husain A, Byrareddy SN. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Chem Biol Interact. 2020;331:109282. doi:10.1016\/j.cbi.2020.109282","DOI":"10.1016\/j.cbi.2020.109282"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Karam BS, Morris RS, Bramante CT, et al. mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses. J Med Virol. 2021;93(4):1843-1846. doi:10.1002\/jmv.26728","DOI":"10.1002\/jmv.26728"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Xia T, Wang Y. Coronavirus disease 2019 and transplantation: the combination of lopinavir\/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome. Am J Transplant. 2020;20(9):2630-2631. doi:10.1111\/ajt.15992","DOI":"10.1111\/ajt.15992"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T04:22:48Z","timestamp":1632284568000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2021\/19\/9\/0\/977\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0232","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}